ZA745443B - Novel preparations containing n-(2-furfuryl)-4-chloro-5-sulfamoyl-anthranilic acid and process for their manufacture - Google Patents

Novel preparations containing n-(2-furfuryl)-4-chloro-5-sulfamoyl-anthranilic acid and process for their manufacture

Info

Publication number
ZA745443B
ZA745443B ZA00745443A ZA745443A ZA745443B ZA 745443 B ZA745443 B ZA 745443B ZA 00745443 A ZA00745443 A ZA 00745443A ZA 745443 A ZA745443 A ZA 745443A ZA 745443 B ZA745443 B ZA 745443B
Authority
ZA
South Africa
Prior art keywords
furfuryl
sulfamoyl
chloro
manufacture
preparations containing
Prior art date
Application number
ZA00745443A
Other languages
English (en)
Inventor
G Ross
G Dahlhausen
H Dibbern
W Fuelberth
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5890849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA745443(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA745443B publication Critical patent/ZA745443B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA00745443A 1973-08-28 1974-08-26 Novel preparations containing n-(2-furfuryl)-4-chloro-5-sulfamoyl-anthranilic acid and process for their manufacture ZA745443B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2343218A DE2343218C2 (de) 1973-08-28 1973-08-28 Furosemid enthaltende Pellets

Publications (1)

Publication Number Publication Date
ZA745443B true ZA745443B (en) 1975-08-27

Family

ID=5890849

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00745443A ZA745443B (en) 1973-08-28 1974-08-26 Novel preparations containing n-(2-furfuryl)-4-chloro-5-sulfamoyl-anthranilic acid and process for their manufacture

Country Status (17)

Country Link
US (1) US4324779A (es)
JP (1) JPS563849B2 (es)
AT (1) AT344914B (es)
BE (1) BE819294A (es)
CA (1) CA1063024A (es)
DE (1) DE2343218C2 (es)
DK (1) DK155173B (es)
EG (1) EG14662A (es)
FI (1) FI249774A (es)
FR (1) FR2242076B1 (es)
GB (1) GB1478715A (es)
HU (1) HU171769B (es)
IL (1) IL45521A (es)
MX (1) MX3585E (es)
NL (1) NL7411269A (es)
SE (1) SE7410788L (es)
ZA (1) ZA745443B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI65910C (fi) * 1976-11-26 1984-08-10 Pennwalt Corp Foerfarande foer framstaellning av farmaceutiska preparat med laongtidsverkan
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4773907A (en) * 1982-12-20 1988-09-27 Alza Corporation Primary delivery system comprising secondary dosage form
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
DE3305935C2 (de) * 1983-02-21 1985-05-30 Medice Chem.-Pharm. Fabrik Pütter GmbH & Co KG, 5860 Iserlohn Kaliumneutrales Saluretikum mit antihypertensiver Wirkung
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
US4663348A (en) * 1985-07-02 1987-05-05 Warner-Lambert Co. Furosemide salts and pharmaceutical preparations thereof
SE460947B (sv) * 1986-08-26 1989-12-11 Lejus Medical Ab En multiple-unit-dos komposition av l-dopa
JPH01130957U (es) * 1988-02-29 1989-09-06
JPH0710747A (ja) * 1993-04-28 1995-01-13 Takeda Chem Ind Ltd 固形製剤およびその製造方法
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
US20070059358A1 (en) * 2003-07-02 2007-03-15 Tianjin Tasly Pharmaceutical Co., Ltd., China Matrix adjuvants and the drop pills prepared with them

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3361632A (en) * 1964-05-08 1968-01-02 Hoechst Ag Medicinal preparations having a protracted activity and method of making them
US3456049A (en) * 1965-05-25 1969-07-15 Ciba Geigy Corp Gradual-release tablet
US3857933A (en) * 1969-10-17 1974-12-31 Hoechst Ag Process for the manufacture of a drug dosage form permitting controlled release of active ingredient
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung

Also Published As

Publication number Publication date
SE7410788L (es) 1975-03-03
CA1063024A (en) 1979-09-25
IL45521A (en) 1978-07-31
US4324779A (en) 1982-04-13
AT344914B (de) 1978-08-25
FR2242076B1 (es) 1978-07-28
ATA694274A (de) 1977-12-15
DK155173B (da) 1989-02-27
IL45521A0 (en) 1974-11-29
JPS5076217A (es) 1975-06-21
MX3585E (es) 1981-03-20
NL7411269A (nl) 1975-03-04
DE2343218A1 (de) 1975-04-03
EG14662A (en) 1984-09-30
AU7272874A (en) 1976-03-04
HU171769B (hu) 1978-03-28
DK455274A (es) 1975-04-28
GB1478715A (en) 1977-07-06
JPS563849B2 (es) 1981-01-27
FR2242076A1 (es) 1975-03-28
FI249774A (es) 1975-03-01
BE819294A (fr) 1975-02-28
DE2343218C2 (de) 1986-08-07

Similar Documents

Publication Publication Date Title
ZA745443B (en) Novel preparations containing n-(2-furfuryl)-4-chloro-5-sulfamoyl-anthranilic acid and process for their manufacture
IL45294A0 (en) 7-acylamido-3-cephem-4-carboxylic acid derivatives and process for their preparation
GB1484606A (en) Substituted amino-benzoic acid derivatives and process for their manufacture
AU7658674A (en) New prostanoic acid derivatives and process for their manufacture
AU8176175A (en) Pyrazolobenzazepines, process for their manufacture and pharmaceutical preparations containing them
IL45628A0 (en) New pyrazolyloxyacetic acid derivatives and process for their manufacture
ZA745912B (en) Novel prostanoic acids and process for their manufacture
IL41811A0 (en) Thiocarbamic acid derivatives and process for their preparation
CA1021348A (en) Oligocarboxy-alkan-phosphonic acid and process for making them
IL45603A0 (en) 7-trichloroacetamido-3-desacetoxy-cephalosporanic acid derivatives and processes for their preparation
IL46064A0 (en) Production of solid preparations containing carbochromene hydrochloride
MW1674A1 (en) Process for the preparation of citric acid and derivativesthereof
EG11252A (en) Process for preparing of n-(aminoacylaminophenyl)acetamidines
ZA757368B (en) New 7,7-diphenyl-hexahydro-1,4-oxazepines,process for their manufacture and pharmaceutical preparations containing them
CA982603A (en) Process for preparing acid amides and pharmaceutical compositions containing same
AU488467B2 (en) Preparations containing n-(2-furfuryl) 4-chloro 5-sulfamoyl-anthranilic acid and process for their manufacture
ZA737959B (en) New 4-ethers of 3-amino-5-sulfamoyl-benzoic acids,process for their manufacture and pharmaceutical preparations containing them
EG11957A (en) Process for the preparation of otaconic acid and derivatives thereof
IL45602A0 (en) 6-trichloroacetamido-penicillanic acid derivatives and processes for their preparation
IL45605A0 (en) 7-monochloroacetamido-3-desacetoxy-cephalosporanic acid derivatives and processes for their preparation
ZA744182B (en) 7-acylamido-3-cephem-4-carboxylic acid derivatives and process for their preparation
KE2891A (en) Diphenoxyacetic acid derivatives and processes for their preparation
IL45604A0 (en) 6-monochloroacetamido-penicillanic acid derivatives and processes for their preparation
AU483801B2 (en) New 4-ethers of 3-amino-5-sulfamoyl-benzoic acids, process for their manufacture and pharmaceutical preparations containing them
CS191425B1 (en) Process for preparing and isolating p-benzaldehydcarbonic acid